Fresenius Medical Care reported €771M of remaining performance obligations at 31 Dec 2025, up 11% from a year earlier. That is 0.0 years of trailing revenue already under contract.
Twelve-month book-to-bill: 1.00, i.e. 1.00 of new orders for every 1 of revenue recognised.
Backlog growth minus revenue growth: +9 points — orders are running ahead of revenue.
Fresenius Medical Care backlog history
Remaining performance obligations at each quarter end (bars) against trailing twelve-month revenue (line).
Amounts in EUR. Source: SEC XBRL filings.
Quarter end
Backlog (RPO)
TTM revenue
Coverage
Customer prepayments
31 Dec 2025
€771M
€19.6B
0.0 yrs
n/a
31 Dec 2024
€698M
€19.3B
0.0 yrs
n/a
31 Dec 2023
€858M
€19.5B
0.0 yrs
n/a
31 Dec 2022
€966M
€19.4B
0.0 yrs
n/a
31 Dec 2021
€1.43B
€17.6B
0.1 yrs
n/a
31 Dec 2020
€1.92B
€17.9B
0.1 yrs
n/a
31 Dec 2019
€1.16B
€17.5B
0.1 yrs
n/a
31 Dec 2018
€1.16B
€16.5B
0.1 yrs
n/a
Questions
What is Fresenius Medical Care's backlog?
Fresenius Medical Care reported €771M of remaining performance obligations at 31 Dec 2025, up 11% from a year earlier. That is 0.0 years of trailing revenue already under contract.
About these numbers
Remaining performance obligations (RPO) are revenue a company has contracted but not yet recognised, as reported in its SEC filings (XBRL tag RevenueRemainingPerformanceObligation). Coverage = backlog ÷ trailing twelve-month revenue. Book-to-bill = (change in backlog + revenue) ÷ revenue. Conversion = revenue recognised ÷ the backlog at the start of each quarter, summed over four quarters. Counterparty values come from company filings and releases.